Marshall Wace North America’s Opko Health OPK Stock Holding History

Marshall Wace North America’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-141,094	Closed	-$605K	–	1673
2021 Q1	$605K	Sell	141,094 -449,980	-76%	-$2.15M	﹤0.01%	1152
2020 Q4	$2.34M	Buy	+591,074	New	+$2.47M	0.01%	714
2019 Q2	–	Sell	-156,855	Closed	-$410K	–	1490
2019 Q1	$410K	Buy	+156,855	New	+$475K	﹤0.01%	847
2018 Q3	–	Sell	-193,098	Closed	-$908K	–	1244
2018 Q2	$908K	Buy	+193,098	New	+$732K	0.01%	950

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Marshall Wace North America's OPK Position: Q2 2021 in Review

Marshall Wace North America sold out of Opko Health (OPK) in Q2 2021, closing a stake of 141,094 shares — an estimated $605K sold.

Marshall Wace North America first reported a position in OPK in Q2 2018 and held it in 4 quarters. The position peaked at $2.34M in Q4 2020. 233 funds tracked by Wall St. Rank hold OPK as of Q2 2021.

Marshall Wace North America reported no remaining Opko Health position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 141,094 Opko Health shares in Q2 2021, an estimated $605K.
Marshall Wace North America first reported a position in Opko Health in Q2 2018 and held it in 4 quarters.
Marshall Wace North America's Opko Health position peaked at $2.34M in Q4 2020.
233 funds tracked by Wall St. Rank held Opko Health as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.